New hope for OCD? brain zaps plus therapy put to the test

NCT ID NCT07146438

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This study is testing whether a noninvasive brain stimulation technique called repetitive Transcranial Magnetic Stimulation (rTMS) can boost the effects of a type of talk therapy (Exposure and Response Prevention) for people with obsessive-compulsive disorder (OCD) that hasn't improved with standard treatment. About 48 adults with OCD will receive rTMS along with either the therapy or supportive counseling. Researchers will also use wearable devices and brain scans to track how well people respond, aiming to find better ways to personalize OCD care.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
repetitive Transcranial Magnetic Stimulation (rTMS) device
What this could lead to
If successful, this could point toward a more personalized, effective treatment for people with OCD that hasn't responded to standard therapy.
What could go wrong
This is a small, early-stage study with only 48 participants, so results may not apply to everyone. The combination of rTMS and therapy may not work better than therapy alone, and rTMS can cause mild side effects like headache or scalp discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBSESSIVE-COMPULSIVE DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Southern California Health Sciences Campus

    RECRUITING

    Los Angeles, California, 90033, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.